Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
| ▸ | OXTR | P30559 | 1/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231881 | 0.84 | PARP1 (0.34) | GAA | |
| SCHEMBL231887 | 0.84 | DYRK1A (0.33) | GAA | |
| SCHEMBL230842 | 0.81 | ALDH1A1 (0.35) | GAAKDM4EMAPTL3MBTL1NPC1 | |
| SCHEMBL230749 | 0.77 | KDM4E (0.34) | GAAKDM4EMAPTL3MBTL1NPC1 | |
| SCHEMBL230650 | 0.77 | LMNA (0.36) | GAAKDM4EMAPTL3MBTL1NPC1 | |
| SCHEMBL163147 | 0.76 | GAA (0.38) | GAAKDM4EMAPTL3MBTL1SMN1; SMN2 | |
| SCHEMBL229675 | 0.76 | LMNA (0.31) | GAAKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL17184104 | 0.75 | MEN1 (0.33) | GAAKDM4EMAPTL3MBTL1NPC1 | |
| SCHEMBL29571581 | 0.68 | ALDH1A1 (0.37) | L3MBTL1MEN1KMT2AALDH1A1 | |
| SCHEMBL230085 | 0.68 | ALDH1A1 (0.37) | L3MBTL1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | US | claimed |
| WO-2010005692-A2 | INSECTICIDAL CYCLIC CARBONYL AMIDINES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-01-14 | — | — | WO | claimed |
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | US | disclosed |
| WO-2010005692-A2 | INSECTICIDAL CYCLIC CARBONYL AMIDINES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | DDT, PRMT9, PNISR | GAA 2667/4885KDM4E 1810/4885MAPT 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.